503 related articles for article (PubMed ID: 29208606)
1. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
Aquino-Jarquin G
Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
4. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
5. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
Du QS; Cui J; Zhang CJ; He K
J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
[TBL] [Abstract][Full Text] [Related]
6. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
8. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
9. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
Zhen S; Li X
Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic applications of CRISPR/Cas9 system in gene therapy.
Mollanoori H; Teimourian S
Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
12. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.
Hussen BM; Rasul MF; Abdullah SR; Hidayat HJ; Faraj GSH; Ali FA; Salihi A; Baniahmad A; Ghafouri-Fard S; Rahman M; Glassy MC; Branicki W; Taheri M
Mil Med Res; 2023 Jul; 10(1):32. PubMed ID: 37460924
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Editing Technology in Biological and Biomedical Investigation.
White MK; Kaminski R; Young WB; Roehm PC; Khalili K
J Cell Biochem; 2017 Nov; 118(11):3586-3594. PubMed ID: 28460414
[TBL] [Abstract][Full Text] [Related]
15. The genome editing revolution: A CRISPR-Cas TALE off-target story.
Stella S; Montoya G
Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
17. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
Li Y; Song YH; Liu B; Yu XY
Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles.
Alinejad T; Modarressi S; Sadri Z; Hao Z; Chen CS
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9557-9575. PubMed ID: 37222810
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
